Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts

scientific article published on 21 August 2013

Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.01581-13
P932PMC publication ID3889777
P698PubMed publication ID23966500

P50authorWalter RicciardiQ13494188
Maurizio SanguinettiQ38325512
Brunella PosteraroQ41881644
Riccardo TorelliQ56285785
Antonietta VellaQ57097027
Elena De CarolisQ57097045
Patrizia PosteraroQ96101917
Flavio De MaioQ97687814
P2093author name stringAlberto Ruggeri
P2860cites workProspective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemiaQ34022724
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.Q34165039
The changing epidemiology of healthcare-associated candidemia over three decadesQ34266632
Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.Q34313668
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Q34372192
Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillanQ34458142
MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyondQ34662276
Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literatureQ34937478
Update on the laboratory diagnosis of invasive fungal infectionsQ35010667
Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolatesQ35140122
Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratoryQ35784345
Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.Q36308069
Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.Q37313058
Epidemiology of invasive mycoses in North AmericaQ37678397
Epidemiology of invasive candidiasisQ37780088
Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic reviewQ37783462
Emerging opportunistic yeast infectionsQ37832837
Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.Q37873554
Uncommon yeast infections in hematological patients: from diagnosis to treatmentQ37949642
Invasive mycoses: diagnostic challengesQ37971083
The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.Q38025819
Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato speciesQ38285146
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?Q43079484
Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospitalQ44627979
Differentiation of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis by specific PCR amplification of the RPS0 intronQ45355167
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.Q45926649
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).Q46072663
Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme.Q51172305
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectspecies identificationQ31887332
P304page(s)3841-3845
P577publication date2013-08-21
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleComparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts
P478volume51

Reverse relations

cites work (P2860)
Q28084765Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy
Q40672124Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification
Q35163632Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species.
Q64281790Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia
Q34351558Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts
Q35839167Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories